nivolumab,ipilimumab
bms
['kudos', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'niche-2']
 #esmo2022 niche-2 talk about a bang! 95% mpr and 67% pcr with neoadjuvant io in dmmr stage ii/iii crc! 6 w of treatment alone! another impressive win to neoadjuvant io!
kudos and team! 
Maria Cecília Mathias - Medical Oncologist and GI Fellow @grupoOncoclínicas ?? Former Oncology Fellow @ ICESP  | ?? Baiana ??????and proud of it! ????